InvestorsHub Logo
Followers 32
Posts 2679
Boards Moderated 0
Alias Born 02/18/2005

Re: Classic Warrior post# 35655

Friday, 05/12/2023 8:30:52 AM

Friday, May 12, 2023 8:30:52 AM

Post# of 36641
The DSMB recommended that the Study be halted early due to statistical significance of the primary endpoint likely not going to be met should the Study continue towards completion. Based on the recommendation from the DSMB, the Company has halted the Study and will now proceed to unblind and seek an evaluation of the Study’s data, including the COVID-19 clinical symptoms data (i.e. cough, fever, heart rate, and oxygen saturation) to determine the potential next clinical and regulatory steps for Bucillamine.